Forbes July 17, 2024
Topline
Shares of Swiss pharma giant Roche climbed Wednesday after it reported promising results for an experimental weight loss pill, part of a cohort of hopeful competitors racing to challenge Novo Nordisk and Eli Lilly in the burgeoning diabetes and obesity drug market amid growing evidence the drugs can treat many other health conditions like kidney disease and sleep apnea.
Key Facts
When will an oral weight loss pill be available?
Roche is one of several companies pushing ahead with oral weight loss drugs in the GLP-1 class, but it is likely to be several years before any reach market. The different mode of delivery, while more convenient and cheaper than frequent injections, raises challenges for delivering the drug at...
Today's Sponsors
Today's Sponsor